-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Xylem, Lowers Price Target to $138

Benzinga·10/28/2026 17:36:03
Diffusion vocale
Goldman Sachs analyst Brian Lee maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $160 to $138.